首页> 外文会议>Annual Meeting of the American Association of Swine Veterinarians >Evaluation of cross-protection afforded by a Salmonella choleraesuis vaccine against Salmonella infections in pigs under field conditions
【24h】

Evaluation of cross-protection afforded by a Salmonella choleraesuis vaccine against Salmonella infections in pigs under field conditions

机译:在现场条件下评估沙门氏菌霍乱症患者患有沙门氏菌疫苗的交叉保护

获取原文

摘要

This field study investigated the efficacy of a Salmonella choleraesuis live vaccine (Argus SC~(TM)) to reduce the number of infections with Salmonella. Twelve groups of about 380 pigs each were randomly allocated to either vaccination (V) or no vaccination (c). The vaccine was applied orally at 3 and 16 weeks. Forty pigs per group were blood sampled at 3, 10, 16 and 24 weeks to detect possible antibodies against Salmonella. The prevalence of Salmonella in the lymph nodes was the major variable. In the V groups, only 0.6 % of the lymph nodes was positive, whereas 7.2% was positive in the C groups (p < 0.001). The percentage of seropositive pigs at 24 weeks (cut-off OD >10) was 26% and 9% in the V and C groups, respectively (p < 0.001). The present study documented that vaccination with a live modified S. Choleraesuis vaccine is a useful tool to lower the prevalence of Salmonella in swine herds.
机译:该田间研究调查了沙门氏菌霍乱活疫苗(Argus Sc〜(TM))的疗效,以减少沙门氏菌的感染数量。每次约380只猪的12个组随机分配给疫苗接种(v)或没有疫苗接种(c)。疫苗在3和16周的口服施用。每组40只猪在3,10,16和24周中取样,以检测对沙门氏菌的可能抗体。淋巴结中的沙门氏菌的患病率是主要变量。在V组中,只有0.6%的淋巴结是阳性的,而C组中7.2%是阳性的(P <0.001)。 24周(截止OD> 10)的血清阳性猪的百分比分别为v和c组的26%和9%(p <0.001)。本研究记录了用活化改性的S.霍乱疫苗的疫苗接种是降低猪群中沙门氏菌患病率的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号